labetalol has been researched along with ketanserin in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (40.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Prichard, BN; Van Zwieten, PA | 1 |
van Zwieten, PA | 1 |
Doyle, AE | 1 |
Barvais, L; Capouet, V; d'Hollander, A | 1 |
Lund-Johansen, P; Omvik, P | 1 |
Bolte, AC; Dekker, GA; van Geijn, HP | 1 |
3 review(s) available for labetalol and ketanserin
Article | Year |
---|---|
Basic pharmacology of alpha-adrenoceptor antagonists and hybrid drugs.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Chemical Phenomena; Chemistry; Humans; Ketanserin; Labetalol; Piperazines | 1988 |
Do hybrid drugs offer an additional benefit over pure alpha 1-blockade for hypertensive patients?
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Humans; Hypertension; Ketanserin; Labetalol; Piperazines | 1988 |
Pharmacological treatment of severe hypertension in pregnancy and the role of serotonin(2)-receptor blockers.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Female; Humans; Hypertension; Ketanserin; Labetalol; Methyldopa; Nitric Oxide Donors; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Receptors, Serotonin; Serotonin Antagonists | 2001 |
7 other study(ies) available for labetalol and ketanserin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
An antihypertensive drug with polyfactor mechanism of action: urapidil.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Brain Chemistry; Cats; Humans; Ketanserin; Labetalol; Piperazines; Rats; Receptors, Adrenergic; Receptors, Serotonin | 1989 |
The haemodynamic effects of labetalol, ketanserin and a placebo at the end of a NLA. A double blind study.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Ethanolamines; Female; Hemodynamics; Humans; Ketanserin; Labetalol; Middle Aged; Piperidines; Placebos; Random Allocation; Serotonin Antagonists; Sympatholytics | 1984 |
Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.
Topics: Adult; Amlodipine; Antihypertensive Agents; Benzeneacetamides; Carbazoles; Carvedilol; Diet, Sodium-Restricted; Diltiazem; Dipeptides; Doxazosin; Exercise; Felodipine; Female; Hemodynamics; Humans; Hypertension; Ketanserin; Labetalol; Lisinopril; Longitudinal Studies; Male; Middle Aged; Propanolamines | 1993 |